Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Open-label, Parallel Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

NCT03547323 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT03547323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03547323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Open-label, Parallel Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Completed
Start date
September 14, 2018
Completion date
June 14, 2019
Enrollment
156 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease